TAG Schedules Informational Meeting on Gene Therapy
October 29, 2010 – TAG (Thalassemia Action Group), the patient-run support group of CAF, will be holding an informational meeting on gene therapy in thalassemia at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City on Sunday, November 14 from 11:30 a.m. to 1:30 p.m.
Entitled “Gene Therapy for Homozygous Beta Thalassemia – Overview and Update,” the meeting will feature a presentation by Drs. Farid Boulad and Michel Sadelain of MSKCC, who have extensive knowledge of and experience in this area and are in the process of developing a thalassemia gene therapy trial themselves.
The meeting is open to individuals with thalassemia and family members of individuals with thalassemia and will be held in room M107, 1275 York Avenue in New York City. The entrance to the building is between 67th and 68th Streets; at the entrance, go up the escalator, make a U-turn and take the hallway leading to the cafeteria. Room M107 is the last room on the left of that first part of the hallway.
Farid Boulad, MD, is Medical Director, Pediatric Day Hospital at MSKCC with clinical expertise in Allogeneic and Autologous Bone Marrow and Peripheral Blood Stem Cell Transplantation. Michel Sadelain, MD, PhD, is Director, Gene Transfer and Somatic Cell Engineering Facility at MSKCC with clinical expertise in Gene Transfer and Genetic Therapies.
The flyer for this event can be downloaded by clicking here. For more information and to RSVP please contact Rucha Shah at firstname.lastname@example.org or Gargi Pahuja at email@example.com. Please RSVP by November 7, 2010.
Have You Chelated Today?
We know that keeping up with chelation can be difficult. Thank you for chelating today.